Undetectable HCV- RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program.

Autor: Bruno, S.¹, Bollani, S.¹, Zignego, A. L.², Pascasio, J. M.³, Magni, C.⁴, Ciancio, A.⁵, Caremani, M.⁶, Mangia, A.⁷, Marenco, S.⁸, Piovesan, S.⁹, Chemello, L.⁹, Babudieri, S.¹⁰, Moretti, A.¹¹, Gea, F.¹², Colletta, C.¹³, Perez‐Alvarez, R.¹⁴, Forns, X.¹⁵, Larrubia, J. R.¹⁶, Arenas, J.¹⁷, Crespo, J.¹⁸

Publikováno v: Journal of Viral Hepatitis. May2015, Vol. 22 Issue 5, p469-480. 12p.

Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

Autor: Bruno, S, Bollani, S., Zignego, A. L., Pascasio, J. M., Magni, C., Ciancio, A., Caremani, M., Mangia, A., Marenco, S., Piovesan, S., Chemello, L., Babudieri, S., Moretti, A., Gea, F., Colletta, C., Perez Alvarez, R., Forns, X., Larrubia, J. R., Arenas, J., Crespo, J., Calvaruso, V., Ceccherini Silberstein, F., Maisonneuve, P., Craxì, A., Calleja, J. L., Di Marco, V., Monti, M., Rizzardini, G., Landonio, S., Rizzetto, M., Lapini, L. E., Piazzolla, V., Picciotto, A., Alberti, A., Cavaletto, L., Koch, M., Massari, M., Muratori, L., Cipriano, V., Montineri, A., Iacobello, C., Fangazio, S., Pirisi, M., Colombo, A., Bellati, G., Mazzotta, F., Pierotti, P., Traverso, A., Serviddio, G., Russello, M., Santantonio, T., Drenaggi, D., Marchionne, E., Zuin, M., Delliponti, M., Farina, F., Andreone, P., Scuteri, A., Galli, M., Giannini, EDOARDO GIOVANNI, Nerli, A., Carbonai, S., Coppola, N., Montalbano, M., Portelli, V., Di Biagio, A., Nicolini, LAURA AMBRA, Mastroianni, C., Madonia, S., Licata, A., Montalto, G., Giannitrapani, L., Mondelli, M., Pellicelli, A., Toniutto, P., Borgia, G., Gentile, I., De Luca, M., Di Costanzo, G. G., Corti, G., Sousa, M., Delgado, M. B., De La Revilla, J., Navarro, J. M., Barcena, R., Romero Gomez, M., Fernandez Rodriguez, C. M., Narvaez, I., Erdozain, J. C., Molina, E., Fernandez, I., Cuenca, B., Planas, R., Garcia Samaniego, J., Ladero, J. M., Gonzalez, J. M., Serra, M. A., Castellote, I., Sola, R., Anton, T., Ryan, I., Gonzalez, F., Martinez, E., Portu, J.

In many countries, first-generation protease inhibitors (PIs)/peginterferon/ribavirin (P/R) still represent the only treatment option for HCV-infected patients. Subjects with advanced disease and previous failure to P/R urgently need therapy, but the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55eee2a0c597fb9dbf1b0b00fe79cea9
http://hdl.handle.net/11390/1190517

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis

Autor: Stroffolini, T, Almasio, Pl, Persico, M, Bollani, S, Benvegnù, L, Di Costanzo, G, Pastore, G, Aghemo, A, Stornaiuolo, G, Mangia, A, Andreone, P, Stanzione, M, Mazzella, G, Saracco, G, Del Poggio, P, Bruno, S, Boccia, S, Di Marco, V, Giannini, EDOARDO GIOVANNI, Morisco, F, Picciotto, Antonino, Fagiuoli, S, Mazzaro, C.

BACKGROUND: While the likelihood of developing hepatocellular carcinoma (HCC) in patients coinfected with both HBV and HCV is increased, the role of previous exposure to HBV as a risk factor associated with tumor occurrence in subjects with HCV-relat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c802b439b8cbbdef9322e591ab72580
http://hdl.handle.net/11577/2264871

Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis

Autor: STROFFOLINI T, PERSICO M, BOLLANI S, BENVEGNÙ L, DI COSTANZO G, PASTORE G, AGHEMO A, STORNAIUOLO G, MANGIA A, ANDREONE P, STANZIONE M, MAZZELLA, G, SARACCO G, DEL POGGIO P, BRUNO S, ITALIAN ASSOCIATION OF THE STUDY OF THE, LIVER DISEASE AISF, ALMASIO, Pier Luigi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3658::d7797c7c2aa34b844daa9f89c6d6e0b8
http://hdl.handle.net/10447/34052